Treating Bladder Cancer: Engineering of Current and Next Generation Antibody-, Fusion Protein-, mRNA-, Cell- and Viral-Based Therapeutics
Bogen, Jan P., Grzeschik, Julius, Jakobsen, Joern, Bähre, Alexandra, Hock, Björn, Kolmar, Harald
Published in Frontiers in oncology (27.05.2021)
Published in Frontiers in oncology (27.05.2021)
Get full text
Journal Article
Synergistic Antitumor Effect of Bispecific CD19 × CD3 and CD19 × CD16 Diabodies in a Preclinical Model of Non-Hodgkin’s Lymphoma
Kipriyanov, Sergey M., Cochlovius, Björn, Schäfer, Holger J., Moldenhauer, Gerhard, Bähre, Alexandra, Le Gall, Fabrice, Knackmuss, Stefan, Little, Melvyn
Published in The Journal of immunology (1950) (01.07.2002)
Published in The Journal of immunology (1950) (01.07.2002)
Get full text
Journal Article
Synergistic Antitumor Effect of Bispecific CD19 x CD3 and CD19 x CD16 Diabodies in a Preclinical Model of Non-Hodgkin's Lymphoma
Kipriyanov, Sergey M, Cochlovius, Bjorn, Schafer, Holger J, Moldenhauer, Gerhard, Bahre, Alexandra, Le Gall, Fabrice, Knackmuss, Stefan, Little, Melvyn
Published in The Journal of immunology (1950) (01.07.2002)
Published in The Journal of immunology (1950) (01.07.2002)
Get full text
Journal Article
Combined effect of recombinant CD19 x CD16 diabody and thalidomide in a preclinical model of human B cell lymphoma
Schlenzka, Jana, Moehler, Thomas M, Kipriyanov, Sergey M, Kornacker, Martin, Benner, Axel, Bähre, Alexandra, Stassar, Marike J J G, Schäfer, Holger J, Little, Melvyn, Goldschmidt, Hartmut, Cochlovius, Björn
Published in Anti-cancer drugs (01.10.2004)
Published in Anti-cancer drugs (01.10.2004)
Get more information
Journal Article